Calculates the AST to Platelet Ratio Index (APRI), a clinical marker used in assessing liver disease severity. This calculation requires two specific blood test values: the serum aspartate aminotransferase (AST) level and the platelet count per cubic millimeter. The resulting ratio provides an estimate of hepatic fibrosis, which is critical for determining the stage of scarring within the liver tissue. Accurate computation of this index assists medical professionals in non-invasive evaluations that complement standard imaging techniques.
Healthcare providers, particularly gastroenterologists and hepatologists, utilize this tool to predict the likelihood and extent of cirrhosis or advanced fibrosis. By obtaining a quick, quantitative estimate of liver damage risk, clinicians can guide further diagnostic testing and recommend appropriate treatment plans.